| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Sheryle Bolton is Director at VBIO. Sheryle Bolton's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5K at current prices.
Net of sales, the VBIO filings show accumulation of 10,000 shares.
Sheryle Bolton has 7 Form 4 filings on record from December 2021 to April 2026, across 2 companies: Director at Valion Bio (VBIO), 2026; Director at Tivic Health Systems (TIVC), 2021–2025.
The 7 reported transactions were 6 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $10K and no sales.
The only open-market purchase was 10,000 shares of VBIO at an average $1.04 on April 15, 2026, about $10K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | VBIO Valion Bio, Inc. | Director | Buy | 10,000 | $1.04 | $10,400.00 | New |